MedTrace Logo

Clinical Evaluation of a Wearable Sleep Diagnosis Technology

NCT03544086 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-12-04

No results posted yet for this study

Summary

The primary endpoint is to evaluate the sensitivities and specificities for diagnosis of sleep apnoea of a wearable sleep diagnosis technology vs. existing gold standard.

Conditions

Sponsors & Collaborators

  • Royal Free Hospital NHS Foundation Trust

    collaborator OTHER

  • Acurable Ltd.

    lead INDUSTRY

Principal Investigators

  • Dr Swapna Mandal, BSc MBBS MRCP SCE, PhD · Royal Free NHS Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-10
Primary Completion
2019-12-30
Completion
2020-09-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03544086 on ClinicalTrials.gov